(Q31013050)

28 June 2017

title

Complete response to donor lymphocyte infusion in multiple myeloma is associated with antibody responses to highly expressed antigens (English)

1 reference

28 June 2017

1 reference

1 reference

lymphocyte transfusion

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563636

22 March 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

22 March 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

22 March 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

22 March 2024

8

Kenneth C Anderson

1 reference

28 June 2017

10

Jerome Ritz

1 reference

28 June 2017

3

Sabina Chiaretti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563636

22 March 2024

5

Faith E. Davies

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563636

22 March 2024

author name string

Roberto Bellucci

1

1 reference

28 June 2017

Edie Weller

4

1 reference

28 June 2017

Glenn Dranoff

7

1 reference

28 June 2017

Catherine J. Wu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563636

22 March 2024

Edwin P. Alyea

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563636

22 March 2024

Nikhil C. Munshi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563636

22 March 2024

language of work or name

English

0 references

publication date

16 October 2003

1 reference

full work available at URL

28 June 2017

published in

Blood

1 reference

28 June 2017

volume

103

1 reference

28 June 2017

issue

2

1 reference

28 June 2017

page(s)

656-663

1 reference

Prognostic factors in allogeneic bone marrow transplantation for multiple myeloma

28 June 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

Molecular remission after allogeneic or autologous transplantation of hematopoietic stem cells for multiple myeloma

22 March 2024

3

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

High rate of remission and low rate of disease recurrence in patients with multiple myeloma allografted with PBSC from their HLA-identical sibling donors

22 March 2024

5

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

Phase I study of busulfan and cyclophosphamide in preparation for allogeneic marrow transplant for patients with multiple myeloma

22 March 2024

6

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

Allogeneic stem cell transplantation for multiple myeloma.

22 March 2024

7

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

Long-term follow-up of T cell-depleted allogeneic bone marrow transplantation in refractory multiple myeloma: importance of allogeneic T cells

22 March 2024

8

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: predictive factors for response and long-term outcome

22 March 2024

10

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

Adoptive immunotherapy for relapsed multiple myeloma after allogeneic bone marrow transplantation (BMT): evidence for a graft-versus-myeloma effect

22 March 2024

11

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

Graft-versus-myeloma effect in two cases

22 March 2024

12

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

Changes in T cell receptor repertoire associated with graft-versus-tumor effect and graft-versus-host disease in patients with relapsed multiple myeloma after donor lymphocyte infusion

22 March 2024

13

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

Antitumor monoclonal antibodies enhance cross-presentation ofcCellular antigens and the generation of myeloma-specific killer T cells by dendritic cells

22 March 2024

15

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

Role of SEREX-defined immunogenic wild-type cellular molecules in the development of tumor-specific immunity

22 March 2024

16

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

ATP6S1 elicits potent humoral responses associated with immune-mediated tumor destruction

22 March 2024

17

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas

22 March 2024

18

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

Melanoma inhibitor of apoptosis protein (ML-IAP) is a target for immune-mediated tumor destruction

22 March 2024

19

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

Serological identification of human tumor antigens

22 March 2024

20

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

Human neoplasms elicit multiple specific immune responses in the autologous host

22 March 2024

21

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

New paths in human cancer serology

22 March 2024

22

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

Antigens recognized by autologous antibody in patients with renal-cell carcinoma

22 March 2024

23

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma

22 March 2024

25

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.

22 March 2024

26

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library

22 March 2024

27

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

22 March 2024

28

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

Humoral immune responses against Wilms tumor gene WT1 product in patients with hematopoietic malignancies

22 March 2024

29

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

T-cell-depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effect

22 March 2024

30

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

Immunologic effects of prophylactic donor lymphocyte infusion after allogeneic marrow transplantation for multiple myeloma

22 March 2024

31

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia

22 March 2024

32

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection

22 March 2024

33

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

The BCMA gene, preferentially expressed during B lymphoid maturation, is bidirectionally transcribed

22 March 2024

34

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

Characterization of single-nucleotide polymorphisms in coding regions of human genes

22 March 2024

35

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia

22 March 2024

36

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

BCMAp: an integral membrane protein in the Golgi apparatus of human mature B lymphocytes

22 March 2024

37

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population

22 March 2024

38

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth

22 March 2024

39

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

22 March 2024

Oncoprotein networks

40

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

Rho GTPases and signaling networks

22 March 2024

41

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

Rho GTPases and the actin cytoskeleton

22 March 2024

42

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I.

22 March 2024

43

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

An essential part for Rho-associated kinase in the transcellular invasion of tumor cells.

22 March 2024

44

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

Rho proteins induce metastatic properties in vivo

22 March 2024

45

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

Prediction of the immunodominant epitope of the pyruvate dehydrogenase complex E2 in primary biliary cirrhosis using phage display.

22 March 2024

46

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

Epitope mapping and reactivity of autoantibodies to the E2 component of 2-oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2-oxoglutarate dehydrogenase complex.

22 March 2024

47

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

Human monoclonal antibodies from a patient with primary biliary cirrhosis that recognize two distinct autoepitopes in the E2 component of the pyruvate dehydrogenase complex

22 March 2024

48

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

Identification of HLA-A2-restricted CD8(+) cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells

22 March 2024

49

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

Homer: a protein that selectively binds metabotropic glutamate receptors

22 March 2024

50

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

Homer regulates the association of group 1 metabotropic glutamate receptors with multivalent complexes of homer-related, synaptic proteins

22 March 2024

51

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

Homer proteins regulate coupling of group I metabotropic glutamate receptors to N-type calcium and M-type potassium channels

22 March 2024

52

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

Agonist-independent activation of metabotropic glutamate receptors by the intracellular protein Homer

22 March 2024

53

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors

22 March 2024

54

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2559

22 March 2024

Identifiers

1 reference

28 June 2017

1 reference